WHO Pharmaceuticals Newsletter 1998, No. 09&10
(1998; 23 pages)
Table of Contents
Open this folder and view contentsRegulatory decisions
Open this folder and view contentsDrug surveillance
Open this folder and view contentsNew developments
Open this folder and view contentsMedical devices
Open this folder and view contentsGeneral information
Open this folder and view contentsMedication errors
Close this folderVeterinary medicine
View the documentClenbuterol-containing veterinary medicines - suspension of indication extended: Germany
View the documentIpronidazole in veterinary medicines - marketing authorization revoked: carcinogenicity: Germany
View the documentLabelling of drugs for use in milk- producing animals - revised regulations: final rule: USA
 

Clenbuterol-containing veterinary medicines - suspension of indication extended: Germany

Germany. The Federal Institute for Health Protection of Consumers and Veterinary Medicine has extended the suspension of the marketing authorization for veterinary products containing clenbuterol intended for the treatment of respiratory diseases in cattle and calves until 31 December 1998.

[See also Pharmaceuticals Newsletter Nos. 9&10, September&October 1997]

Reference: Deutsche Apotheker Zeitung 138 (32): 2958, 6 August 1997.

to previous section to next section
 

Last updated: May 3, 2013